This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Sep 2026 consolidated Q2: revenue up 226% year-on-year; profit after tax Rs 2,883 vs Rs 78 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 5.3 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated revenue for the quarter ended 30 September 2026 rose 225.6% to Rs 9,752.26 lakh from Rs 2,995.05 lakh a year earlier, while profit after tax rose to Rs 2,883.17 lakh from Rs 78.09 lakh. The board approved these unaudited results. Half-year consolidated operating cash flow was negative Rs 55.42 lakh. The auditor raised no material issue, but the new Saudi unit had no revenue and a Rs 127.02 lakh loss, making comparisons uneven.
Strong growth may support the stock, but negative operating cash flow, the new subsidiary's loss and weaker comparability are key risks.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹87.52 Cr | ₹29.95 Cr | +192.2% |
| Operating profit | ₹19.75 Cr | ₹0.33 Cr | +5,854.7% |
| Profit after tax | ₹16.77 Cr | ₹0.91 Cr | +1,750.1% |
| EBITDA margin | 24.6% | 5.3% | +19.3 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.